Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 399 Binney St, Suite 300,united States
- Phone
- (617)218-1606
- in****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- rubiustx.com
- HQ
- Cambridge, Massachusetts
Rubius Therapeutics Questions
Rubius Therapeutics's helpline number is (617)218-1606
Rubius Therapeutics's website is rubiustx.com
Rubius Therapeutics's LinkedIn profile is https://www.linkedin.com/company/rubius-therapeutics
Rubius Therapeutics has
19 employees.
View email and phone details for 19
employees at Rubius Therapeutics.
Rubius Therapeutics's industry is
Biotechnology Research
Rubius Therapeutics's top competitors are
Vertex Pharmaceuticals,
Magenta Therapeutics,
Tango Therapeutics,
Kaleido Biosciences,
Editas Medicine,
Seres Therapeutics,
Tessera Therapeutics,
Intellia Therapeutics, Inc.,
Beam Therapeutics,
Sarepta Therapeutics.
Rubius Therapeutics's support email address is info@rubiustx.com
Rubius Therapeutics's categories are Biotechnology Research
Rubius Therapeutics's founding year is 2014
